These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2624243)

  • 1. Mechanisms and consequences of complement activation during hemodialysis.
    Kazatchkine MD; Haeffner-Cavaillon N
    Adv Exp Med Biol; 1989; 260():19-26. PubMed ID: 2624243
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranes.
    Schindler R; Lonnemann G; Shaldon S; Koch KM; Dinarello CA
    Contrib Nephrol; 1989; 74():58-65. PubMed ID: 2702147
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. II. Interleukin-1 production.
    Herbelin A; Ureña P; Man NK; Drüeke T; Descamps-Latscha B
    Contrib Nephrol; 1989; 74():79-85. PubMed ID: 2702150
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems.
    Moll S; De Moerloose P; Reber G; Schifferli J; Leski M
    Int J Artif Organs; 1990 May; 13(5):273-9. PubMed ID: 2142140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of hemodialysis membranes: a study in healthy subjects.
    Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW
    Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of acute leukopenia in hemodialysis. Role of direct leukocyte and dialyzer membrane interaction].
    Pacitti A; Segoloni G; Triolo G; Tetta C; Messina M; Bussolino F; Camussi G; Ragni R; Martini PF; Coppo R; Vercellone A
    Minerva Nefrol; 1980; 27(4):651-3. PubMed ID: 7254693
    [No Abstract]   [Full Text] [Related]  

  • 7. Biocompatibility criteria in hemodialysis.
    Cordonnier DJ; Forêt M
    Contrib Nephrol; 1989; 71():30-5. PubMed ID: 2680263
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodialysis leukopenia and complement function with different dialyzers.
    Amadori A; Candi P; Sasdelli M; Massai G; Favilla S; Passaleva A; Ricci M
    Kidney Int; 1983 Dec; 24(6):775-81. PubMed ID: 6562280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow-cytometric study of granulocyte activation during hemodialysis with different membranes.
    Mordacchini M; Teodori T; Collodel L; Celeghin A; Fregonese A; Vianello A
    Blood Purif; 1995; 13(6):322-6. PubMed ID: 8821196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of interleukin-1 during hemodialysis.
    Haeffner-Cavaillon N; Jahns G; Poignet JL; Kazatchkine MD
    Kidney Int Suppl; 1993 Jan; 39():S139-43. PubMed ID: 8468916
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemodialysis-induced leucopenia and activation of complement: effects of different membranes.
    Aljama P; Bird PA; Ward MK; Feest TG; Walker W; Tanboga H; Sussman M; Kerr DN
    Proc Eur Dial Transplant Assoc; 1978; 15():144-53. PubMed ID: 740661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of cytokines in hemodialysis.
    Tetta C; Camussi G; Turello E; Salomone M; Aimo G; Priolo G; Segoloni G; Vercellone A
    Blood Purif; 1990; 8(6):337-46. PubMed ID: 2093331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of beta 2-microglobulin by adsorption on dialysis membranes.
    Goldman M; Dhaene M; Vanherweghem JL
    Nephrol Dial Transplant; 1987; 2(6):576-7. PubMed ID: 3126461
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokine production during hemodialysis: effects of dialytic membrane and complement activation.
    Lin YF; Chang DM; Shaio MF; Lu KC; Chyr SH; Li BL; Sheih SD
    Am J Nephrol; 1996; 16(4):293-9. PubMed ID: 8739281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. I. Radiolabeled endotoxin.
    Ureña P; Herbelin A; Basile C; Zingraff J; Man NK; Drüeke T
    Contrib Nephrol; 1989; 74():71-8. PubMed ID: 2702149
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukopenia and complement activation induced by different dialysis membranes.
    Man NK; Tien NQ; Lesavre P; Funck-Brentano JL
    Contrib Nephrol; 1984; 37():142-8. PubMed ID: 6713867
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of the AN69-S (Biospal) in conventional hemodialysis (HD) and in biofiltration (BF).
    Pisani E; Axia M; Morrone A; Carollo G
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():75-7. PubMed ID: 3557679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phagocytic activity of leukocytes induced by different dialyzer membranes.
    Vanholder R; Dhondt A; Van Landschoot N; Waterloos MA; Ringoir S
    Contrib Nephrol; 1989; 74():86-90. PubMed ID: 2518453
    [No Abstract]   [Full Text] [Related]  

  • 20. Complement activation during hemodialysis.
    Agostoni A; Gardinali M
    J Biomater Appl; 1989 Oct; 4(2):102-22. PubMed ID: 2677307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.